Average Co-Inventor Count = 4.01
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (20 from 2,405 patents)
2. Usher III Initiative, Inc. (9 from 9 patents)
3. Merck + Co., Inc. (3 from 4,770 patents)
4. Janssen Pharmaceutica Nv (2 from 2,079 patents)
33 patents:
1. 10307422 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
2. 9925187 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
3. 9783545 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
4. 9549910 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
5. 9371332 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome
6. 9260381 - Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome
7. 9227976 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
8. 9079909 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome
9. 8778966 - Quinolinone derivatives as PARP and tank inhibitors
10. 8765762 - Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome
11. 8299256 - Quinolinone derivatives as PARP and TANK inhibitors
12. 7655675 - Gamma-secretase inhibitors
13. 7598386 - Sulphones which modulate the action of gamma-secretase
14. 7595344 - Sulphones which modulate the action of gamma secretase
15. 7410964 - Cyclohexyl sulphones as gamma-secretase inhibitors